Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Lyophilized Injectable Market – Latest Trends and Future Growth Study by 2031

Lyophilized Injectable Market: Introduction

According to the report, the global lyophilized injectable market was valued over US$ 2.8 Bn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Lyophilization is a freeze-drying process used for the removal of water from the final product. In lyophilization, the output product is frozen under high vacuum. Lyophilization is used in the biotechnological and pharmaceutical manufacturing industries for the production of good quality products with expanded lifespan.

Presently, lyophilized injection dosage form is extensively used to improve bioavailability, stability, solubility, and patient compliance. Lyophilized injection is considered an alternative to oral solid dosage forms for better patient compliance, especially in bedridden patients and for attaining maximum bioavailability and improved stability.

Expansion of Pipeline of Lyophilized Injectable Drugs to Drive Global Market

The continuous research & development to develop innovative drugs for the treatment of chronic diseases has propelled the development of lyophilized injectable drugs in the pharmaceutical industry. Product innovation and acquisition provide key players with the opportunities to penetrate a new therapeutic area/market. About 2,400 injectable products are presently in the development pipeline. This is expected to augment the global lyophilized injectable market.

Request Brochure of Report –

Development of Alternative Methods to Hamper Market Growth

Lyophilization of injectable drugs is an expensive process. Hence, manufacturers strive to develop alternative drying methods to increase the shelf life of products, which can prove economical. However, such alternative processes need improvement in terms of retaining stability and biological or chemical activity of the substance. Roche has developed a precipitation method as an alternative to lyophilization for the production of peptides, which enabled the company to reduce production costs, and deliver an effective, quality, and affordable product to customers. The advent of alternative methods during the forecast period is likely to hamper the growth of the global lyophilized injectable market.

Single-use Vials Dominated Global Market

The report offers detailed segmentation of the global lyophilized injectable market based on type of packaging, type of delivery, indication, and end user. In terms of type of packaging, the single-use vials segment dominated the global market in 2020. The increase in self-administration of lyophilized injectable drugs to treat various chronic conditions such as diabetes, rheumatoid arthritis, and migraine is projected to drive the single-use vials segment during the forecast period. The specialty packaging segment is expected to grow at a rapid pace from 2021 to 2031, as the segment offers packaging solutions such as pens, needle-free injectors, and two-part syringes that allow reconstitution in the device prior to injection.

Request for Custom Research –

Hospitals to be Major End User

In terms of end user, the lyophilized injectable market has been divided into hospitals, ambulatory surgical centers, specialty clinics, and others The hospitals segment is expected to expand at a high CAGR during the forecast period, due to increase in the number of hospitals and high patient preference to visit hospitals for treatment.

North America to Dominate Global Market

The global lyophilized injectable market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global lyophilized injectable market in 2020, followed by Europe. North America accounted for a major share of the global lyophilized injectable market in 2020, due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of healthcare infrastructure. Additionally, presence of a large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs.

Buy Lyophilized Injectable Market Report –

Competition Landscape

The report also presents profiles of leading players in the global lyophilized injectable market. These include B. Braun Melsungen AG, Baxter International, Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, and Jubilant HollisterStier LLC.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Mr. Rohit Bhisey

Transparency Market Research

USA – Canada Toll Free: 866-552-3453



Follow UsTwitter | LinkedIn

Press Release Source:

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts